Inova secures EUA for SARS-CoV-2 assay

LabPulse.com staff writers
May 9, 2021
2021 05 10 22 34 9372 Bio Flash Shadow 400

Inova Diagnostics has secured emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Quanta Flash SARS-CoV-2 immunoglobulin G (IgG) assay.

The assay is for use on the company's Bio-Flash random access chemiluminescent analyzer, which has a processing capacity of up to 60 samples per hour, according to the firm. It has shown 100% specificity for identifying SARS-CoV-2 in patients "with confounding conditions" and 100% sensitivity for COVID-19 in patients 15 days after a positive reverse transcription polymerase chain reaction (RT-PCR) result, Inova said.

Inova Diagnostics' Quanta Flash rapid response chemiluminescent assay runs on the Bio-Flash lab analyzer. Image courtesy of Inova Diagnostics.Inova Diagnostics' Quanta Flash rapid response chemiluminescent assay runs on the Bio-Flash lab analyzer. Image courtesy of Inova Diagnostics.
Latest in COVID-19
Artificial Intelligence Ai Hand Social
AI model shows promise detecting COVID-19 in low-resource settings
November 14, 2023
Coronavirus Hologram Blue Social
3EO Health to launch FDA-approved COVID-19 test
October 20, 2023
Coronavirus Covid Blue Social
Researchers develop technique for onsite detection of SARS-CoV-2
October 10, 2023
3d Closeup Coronavirus Social
FDA issues EUAs for 2 POC COVID-19 tests
October 4, 2023
Related Stories
2021 06 30 21 55 5977 2021 06 29 Inova Aptiva 400
CE mark
Inova's Aptiva autoimmune disease assay gets FDA nod
2020 08 26 22 23 0503 2020 08 26 Inova 400
CE mark
Inova gets CE Mark for autoimmune assays
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
COVID-19
Thermo Fisher unveils assay panel to detect SARS-CoV-2 variants
2020 07 07 21 58 5498 Swab Sample Collection 400
COVID-19
Saliva tests may be effective in diagnosing COVID-19
More in COVID-19
AI model shows promise detecting COVID-19 in low-resource settings
An artificial intelligence (AI) model shows promise for diagnosing COVID-19 in low-resource settings with severe shortages of medical experts, including in many African regions, according to a study published November 11 in Scientific Reports.
November 14, 2023
Artificial Intelligence Ai Hand Social
3EO Health to launch FDA-approved COVID-19 test
Molecular diagnostics startup 3EO Health is preparing to launch a newly approved SARS-CoV-2 test with its portable molecular device, saying it will “expand access” to the technology.
October 20, 2023
Coronavirus Hologram Blue Social
Researchers develop technique for onsite detection of SARS-CoV-2
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Coronavirus Covid Blue Social
FDA issues EUAs for 2 POC COVID-19 tests
The U.S. Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for two separate point-of-care (POC) assays for SARS-CoV-2 developed by Tangen Biosciences and SD Biosensor.
October 4, 2023
3d Closeup Coronavirus Social
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
U.S. government investing $600M in COVID-19 test manufacturing
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Report: Lack of standardization a ‘huge’ issue during pandemic, problems persist
A lack of standardization of infectious disease consumables was “a huge, unanticipated issue during the pandemic” that still needs to be resolved, according to a report in GenomeWeb.
September 15, 2023
Doctor Nurse Mask Icu Social
Whistleblower claims CIA analysts were bribed to reject COVID-19 'lab leak' origin hypothesis
A whistleblower gave testimony to two panels of the House of Representatives alleging that six CIA analysts were bribed to reject the theory that the COVID-19 pandemic resulted from a research-related leak of a new coronavirus.
September 15, 2023
Infectious Diseases Research Social
Study: Blood clotting proteins may contribute to COVID-19 'brain fog,' cognitive problems
The presence of blood clots may help explain cognitive problems such as "brain fog" in patients following COVID-19 infection, say researchers.
September 13, 2023
Covid Brain Visual Social
Researchers create low-cost, eco-friendly COVID-19 test
Scientists say they have engineered an accurate, low-cost, and eco-friendly COVID-19 test that could dramatically reduce environmental waste.
September 12, 2023
Nasal Swab Test Social
NIH study shows value of repeat use of COVID-19 antigen tests
Researchers have published the performance data that prompted the U.S. Food and Drug Administration to revise its position on COVID-19 testing last year.
September 11, 2023
Covid Diagnostic Test Kit Social
Single-cell sequencing shows population-level drivers of COVID-19 responses
To assess population-level variation, the researchers performed single-cell RNA sequencing on peripheral blood mononuclear cells taken from 222 healthy donors of diverse ancestries.
August 15, 2023
Covid Virus Dna Molecule Social
Page 1 of 34
Next Page